News
$Carisma Therapeutics (CARM.US)$ Reuters· 1 min ago
Carisma Therapeutics Granted FDA Fast Track Designation for Ct-0525 for the Treatment of Her2-Overexpressing Solid Tumors
Carisma Therapeutics Granted FDA Fast Track Designation for Ct-0525 for the Treatment of Her2-Overexpressing Solid Tumors
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment